palmitoylethanolamide

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf fatty acid amide
endogenous compound
gptkbp:actsOn gptkb:CB1_receptor
gptkb:CB2_receptor
gptkb:GPR119
GPR55
peroxisome proliferator-activated receptor alpha (PPAR-α)
gptkbp:CASNumber 544-31-0
gptkbp:category dietary supplement
nutraceutical
lipid mediator
endocannabinoid-like molecule
gptkbp:chemicalFormula C18H37NO2
gptkbp:discoveredBy gptkb:Rita_Levi-Montalcini
gptkbp:effect analgesic
anti-inflammatory
neuroprotective
gptkbp:firstDescribed 1957
gptkbp:foundIn garlic
corn
soybeans
peanuts
soybean oil
alfalfa
egg yolk
lupin
oat
soy lecithin
peanut oil
https://www.w3.org/2000/01/rdf-schema#label palmitoylethanolamide
gptkbp:IUPACName N-(2-hydroxyethyl)hexadecanamide
gptkbp:metabolism N-acylethanolamine acid amidase (NAAA)
fatty acid amide hydrolase (FAAH)
gptkbp:molecularWeight 299.49 g/mol
gptkbp:notScheduled gptkb:United_States
gptkbp:relatedTo gptkb:anandamide
oleoylethanolamide
gptkbp:routeOfAdministration oral
topical
sublingual
gptkbp:usedFor gptkb:carpal_tunnel_syndrome
osteoarthritis
multiple sclerosis
peripheral neuropathy
chronic pain
respiratory infections
fibromyalgia
inflammatory disorders
interstitial cystitis
gptkbp:bfsParent gptkb:fatty_acid_amide_hydrolase
gptkbp:bfsLayer 7